The University of Pittsburgh Medical Center is recruiting nonsmoking adults with asthma for a study that will help determine whether vitamin D enhances asthma treatment with inhalers by reducing inflammation.
Researchers at the University of Pittsburgh Asthma Institute and the School of Medicine are recruiting 50 patients, who will be among 400 people selected randomly from 1,600 people screened nationwide for the study.
Participants must be at least 18, be diagnosed with asthma and nonsmoking. They will be compensated. For more information, please call 1-866-804-5278 or visit www.asthmainstitute.pitt.edu
The study focus is determining whether Vitamin D in addition to the inhaled steroid -- the most effective treatment for asthma available today -- will help prevent worsening asthma symptoms in people who have low Vitamin D. It is estimated that up to 30 percent of the population has low Vitamin D levels.
The VIDA Study is supported by the AsthmaNET Grant awarded to the Asthma Institute in November 2010. AsthmaNet is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. The University of Pittsburgh is one of nine AsthmaNet research sites across the United States participating in this study.